Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03691766 · ClinicalTrials.gov registry record · NA
Photobiomodulation Therapy in Persons With Multiple Sclerosis
A NA study, sponsored by Marquette University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03691766 is a NA study that has completed, run by Marquette University. The registered enrollment target is 21 participants.
The verdict
NCT03691766, a NA study, has completed, sponsored by Marquette University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study will test whether photobiomodulation therapy improves muscle endurance and decreases inflammation in persons with relapsing-remitting multiple sclerosis. We will also investigate mechanisms for any improvements.
Interventions
- OTHER Placebo
- OTHER Photobiomodulation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-04-30 |
| Est. Completion | 2019-09-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03691766
The ClinicalTrials.gov registry entry for NCT03691766 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Marquette University, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03691766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03691766 about?
NCT03691766 is a clinical study titled "Photobiomodulation Therapy in Persons With Multiple Sclerosis". This study will test whether photobiomodulation therapy improves muscle endurance and decreases inflammation in persons with relapsing-remitting multiple sclerosis. We will also investigate mechanisms for any improvements.
What is the current status of trial NCT03691766?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2018-04-30. Estimated completion is 2019-09-23.
What interventions are being tested in trial NCT03691766?
The interventions under investigation include: Placebo (OTHER), Photobiomodulation Therapy (OTHER).
Who is sponsoring clinical trial NCT03691766?
This trial is sponsored by Marquette University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.